Literature DB >> 9344537

Expression of betacellulin and epiregulin genes in the mouse uterus temporally by the blastocyst solely at the site of its apposition is coincident with the "window" of implantation.

S K Das1, N Das, J Wang, H Lim, B Schryver, G D Plowman, S K Dey.   

Abstract

In the mouse, the process of implantation is initiated by the attachment reaction between the blastocyst trophectoderm and uterine luminal epithelium that occurs at 2200-2300 h on day 4 (day 1 = vaginal plug) of pregnancy. Several members of the EGF family are considered important in embryo-uterine interactions during implantation. This investigation demonstrates that the expression of two additions to the family, betacellulin and epiregulin, are exquisitely restricted to the mouse uterine luminal epithelium and underlying stroma adjacent to the implanting blastocyst. These genes are not expressed during progesterone-maintained delayed implantation, but are rapidly switched on in the uterus surrounding the implanting blastocyst following termination of the delay by estrogen. These results provide evidence that expression of betacellulin and epiregulin in the uterus requires the presence of an active blastocyst and suggest an involvement of these growth factors in the process of implantation. Copyright 1997 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9344537     DOI: 10.1006/dbio.1997.8694

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  19 in total

1.  Human effector/initiator gene sets that regulate myometrial contractility during term and preterm labor.

Authors:  Carl P Weiner; Clifford W Mason; Yafeng Dong; Irina A Buhimschi; Peter W Swaan; Catalin S Buhimschi
Journal:  Am J Obstet Gynecol       Date:  2010-05       Impact factor: 8.661

2.  Canonical Wnt signaling is critical to estrogen-mediated uterine growth.

Authors:  Xiaonan Hou; Yi Tan; Meiling Li; Sudhansu K Dey; Sanjoy K Das
Journal:  Mol Endocrinol       Date:  2004-09-09

3.  Uterine Wnt/beta-catenin signaling is required for implantation.

Authors:  Othman A Mohamed; Maud Jonnaert; Cassandre Labelle-Dumais; Kazuki Kuroda; Hugh J Clarke; Daniel Dufort
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-01       Impact factor: 11.205

4.  Hormone dependent uterine epithelial-stromal communication for pregnancy support.

Authors:  Xiaoqiu Wang; San-Pin Wu; Francesco J DeMayo
Journal:  Placenta       Date:  2017-07-06       Impact factor: 3.481

Review 5.  The role of Wnt signaling members in the uterus and embryo during pre-implantation and implantation.

Authors:  Filiz Tepekoy; Gokhan Akkoyunlu; Ramazan Demir
Journal:  J Assist Reprod Genet       Date:  2014-12-24       Impact factor: 3.412

Review 6.  Epiregulin: roles in normal physiology and cancer.

Authors:  David J Riese; Richard L Cullum
Journal:  Semin Cell Dev Biol       Date:  2014-03-12       Impact factor: 7.727

7.  The profile of the epidermal growth factor system in rat endometrium during postpartum involution period.

Authors:  Emel Alan; Narin Liman; Hakan Sağsöz
Journal:  Vet Res Commun       Date:  2015-03-11       Impact factor: 2.459

8.  Maternal heparin-binding-EGF deficiency limits pregnancy success in mice.

Authors:  Huirong Xie; Haibin Wang; Susanne Tranguch; Ryo Iwamoto; Eisuke Mekada; Francesco J Demayo; John P Lydon; Sanjoy K Das; Sudhansu K Dey
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-06       Impact factor: 11.205

9.  Defective valvulogenesis in HB-EGF and TACE-null mice is associated with aberrant BMP signaling.

Authors:  Leslie F Jackson; Ting Hu Qiu; Susan W Sunnarborg; Aileen Chang; Chunlian Zhang; Cam Patterson; David C Lee
Journal:  EMBO J       Date:  2003-06-02       Impact factor: 11.598

10.  Epiregulin is not essential for development of intestinal tumors but is required for protection from intestinal damage.

Authors:  Daekee Lee; R Scott Pearsall; Sanjoy Das; Sudhansu K Dey; Virginia L Godfrey; David W Threadgill
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.